[go: up one dir, main page]

AR068187A1 - Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv - Google Patents

Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv

Info

Publication number
AR068187A1
AR068187A1 ARP080102995A ARP080102995A AR068187A1 AR 068187 A1 AR068187 A1 AR 068187A1 AR P080102995 A ARP080102995 A AR P080102995A AR P080102995 A ARP080102995 A AR P080102995A AR 068187 A1 AR068187 A1 AR 068187A1
Authority
AR
Argentina
Prior art keywords
inhibitor
preparation
dpp
crystal form
crystalline form
Prior art date
Application number
ARP080102995A
Other languages
English (en)
Inventor
Zhen-Ping Wu
Original Assignee
Phenomix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomix Corp filed Critical Phenomix Corp
Publication of AR068187A1 publication Critical patent/AR068187A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion provee una forma cristalina de un intermediario sintético de utilidad en la preparacion de un inhibidor de DPP-IV, un método de preparacion de la forma cristalina del intermediario y un método de uso de la forma cristalina del intermediario en la preparacion del inhibidor. Utiles para el tratamiento de la diabetes mellitus. Reivindicacion 1: Una forma cristalina de un compuesto de la formula (1).
ARP080102995A 2007-07-12 2008-07-11 Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv AR068187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95922607P 2007-07-12 2007-07-12

Publications (1)

Publication Number Publication Date
AR068187A1 true AR068187A1 (es) 2009-11-11

Family

ID=40229094

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102995A AR068187A1 (es) 2007-07-12 2008-07-11 Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv

Country Status (8)

Country Link
US (1) US20100204484A1 (es)
EP (1) EP2175727A4 (es)
AR (1) AR068187A1 (es)
CA (1) CA2692758A1 (es)
CL (1) CL2008002044A1 (es)
MX (1) MX2010000501A (es)
TW (1) TW200927144A (es)
WO (1) WO2009009751A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MY164581A (en) 2008-08-15 2018-01-15 Boehringer Ingelheim Int Purin derivatives for use in the treatment of fab-related diseases
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
TWI466672B (zh) 2009-01-29 2015-01-01 Boehringer Ingelheim Int 小兒科病人糖尿病之治療
EA029759B1 (ru) 2009-02-13 2018-05-31 Бёрингер Ингельхайм Интернациональ Гмбх Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EP3646859A1 (en) 2009-11-27 2020-05-06 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
US20130109703A1 (en) 2010-03-18 2013-05-02 Boehringer Ingelheim International Gmbh Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions
AU2011249722B2 (en) 2010-05-05 2015-09-17 Boehringer Ingelheim International Gmbh Combination therapy
CN106975074A (zh) 2010-06-24 2017-07-25 勃林格殷格翰国际有限公司 糖尿病治疗
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496163A (en) * 1965-02-08 1970-02-17 Upjohn Co 7-halo-7-deoxylincomycins and process for preparing the same
US5329012A (en) * 1987-10-29 1994-07-12 The Research Foundation Of State University Of New York Bis(acyloxmethyl)imidazole compounds
US20100087658A1 (en) * 1996-08-06 2010-04-08 Phenomix Corporation Methods and intermediates for synthesis of selective dpp-iv inhibitors
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7317109B2 (en) * 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) * 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CN101232890A (zh) * 2005-08-01 2008-07-30 芬诺密克斯公司 制备杂环硼酸及其衍生物的方法
WO2007038676A2 (en) * 2005-09-28 2007-04-05 Teva Pharmaceutical Industries Ltd. Polymorphic forms of ladostigil tartrate

Also Published As

Publication number Publication date
TW200927144A (en) 2009-07-01
MX2010000501A (es) 2011-05-25
US20100204484A1 (en) 2010-08-12
CL2008002044A1 (es) 2009-01-16
CA2692758A1 (en) 2009-01-15
WO2009009751A1 (en) 2009-01-15
EP2175727A1 (en) 2010-04-21
EP2175727A4 (en) 2011-05-25

Similar Documents

Publication Publication Date Title
AR068187A1 (es) Forma cristalina de un intermediario sintetico para la preparacion de un inhibidor de dpp-iv
CL2012001348A1 (es) Sal cristalina de hemitartrato del compuesto genz-112638, inhibidor de glucosilceramida sintetasa; composición farmacéutica que la comprende;y su uso en el tratamiento de la enfermedad de gaucher y enfermedad de fabry.
DOP2012000150A (es) Triazolopiridinas
NO20090173L (no) Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
DOP2009000266A (es) Compuestos quimicos
CU20140068A7 (es) Triazolopiridinas sustituidas
WO2010063700A3 (en) Novel pyrazole-4 -n-alkoxycarboxamides as microbiocides
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
EA201100969A1 (ru) Солевые формы органического соединения
UY30228A1 (es) Compuestos quimicos
CR7680A (es) Un nuevo proceso para la sintesis de agomelatina
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
WO2009024342A3 (en) Novel microbiocides
ECSP13013011A (es) Triazolopiridinas
ECSP077984A (es) Formulacion de un inhibidor de agregacion de plaquetas de tienopiridina
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
ECSP11010878A (es) Formas cristalinas de un derivado de 2-tiazolil-4-quinolinil-oxi, un potente inhibidor de hcv.
ECSP12012338A (es) Triazolopiridinas sustituidas
PA8666701A1 (es) Nueva sal y polimorfos del inhibidor de la dpp-iv
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
UY29459A1 (es) Forma cristalina ortorrómbica del maleato de asenapina y su uso en el tratamiento de trastornos mentales
WO2008151828A3 (en) Novel microbiocides
DOP2009000207A (es) Nueva forma de dosificación
WO2009127718A3 (en) Novel microbiocides
BRPI0912388A2 (pt) composto, forma cristalina, processo para preparar compostos, composição farmacêutica, e, uso de um composto, e, método para o tratamento ou profilaxia de doenças

Legal Events

Date Code Title Description
FB Suspension of granting procedure